Stocks / NASDAQ / Mainz Biomed B.V.

Mainz Biomed B.V.

Industry:   Health Care - Biotechnology: Pharmaceutical Preparations Stock Symbol:   MYNZ - NASDAQ Animal Usage:   Animal Testing, Uncertain

Our Opinion

Mainz Biomed B.V. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Company Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Company Website: https://www.mainzbiomed.com

Contact:   https://mainzbiomed.com/contact